| Medical and Health Sciences | Lifetime | 698 | US 363 | 99.97 |
| Medical and Health Sciences | 2021-2025 | 491 | US 169 | 99.90 |
| Psychiatry and Mental health | Lifetime | 39 | US 22 | 99.89 |
| Pathology and Forensic Medicine | Lifetime | 88 | US 48 | 99.65 |
| Medical Physiology | Lifetime | 692 | US 358 | 98.79 |
| Clinical Neurology | Lifetime | 549 | US 241 | 97.55 |
| Sensory Systems | Lifetime | 597 | US 299 | 82.37 |
| Psychiatry and Mental health | 2021-2025 | 20 | US 8 | 99.77 |
| Pathology and Forensic Medicine | 2021-2025 | 97 | US 37 | 97.84 |
| Clinical Neurology | 2021-2025 | 351 | US 143 | 88.93 |
| Migraine and Headache Studies | Lifetime | 4 | US 2 | 99.83 |
| Trigeminal Neuralgia and Treatments | Lifetime | 4 | US 2 | 99.90 |
| Sympathectomy and Hyperhidrosis Treatments | Lifetime | 4 | US 2 | 99.87 |
| Neurological Complications and Syndromes | Lifetime | 10 | US 7 | 99.56 |
| Ophthalmology and Eye Disorders | Lifetime | 20 | US 8 | 99.64 |
| Cardiovascular Syncope and Autonomic Disorders | Lifetime | 26 | US 14 | 99.49 |
| Psychosomatic Disorders and Their Treatments | Lifetime | 45 | US 17 | 99.41 |
| Neuroprotection in Stroke and Neurodegeneration | Lifetime | 60 | US 27 | 99.28 |
| Olfactory and Sensory Function Studies | Lifetime | 79 | US 38 | 98.89 |
| Neurosurgical Procedures and Complications | Lifetime | 73 | US 42 | 99.19 |
| Cerebral Venous Sinus Thrombosis | Lifetime | 194 | US 103 | 97.43 |
| Botulinum Toxin and Related Neurological Disorders | Lifetime | 707 | US 283 | 96.55 |
| Intracerebral and Subarachnoid Hemorrhage Research | Lifetime | 639 | US 254 | 95.45 |
| Cerebrovascular and genetic disorders | Lifetime | 214 | US 56 | 92.04 |
| Restraint-Related Deaths | Lifetime | 539 | US 215 | 87.39 |
| Historical and Scientific Studies | Lifetime | 687 | US 84 | 75.48 |
| Oropharyngeal Anatomy and Pathologies | Lifetime | 972 | US 240 | 66.94 |
| Neuroprotection in Stroke and Neurodegeneration | 2021-2025 | 3 | US 1 | 98.22 |
| Migraine and Headache Studies | 2021-2025 | 6 | US 2 | 99.64 |
| Neurological Complications and Syndromes | 2021-2025 | 4 | US 1 | 98.09 |
| Trigeminal Neuralgia and Treatments | 2021-2025 | 6 | US 2 | 99.62 |
| Psychosomatic Disorders and Their Treatments | 2021-2025 | 22 | US 8 | 98.28 |
| Sympathectomy and Hyperhidrosis Treatments | 2021-2025 | 9 | US 2 | 98.62 |
| Ophthalmology and Eye Disorders | 2021-2025 | 61 | US 20 | 94.63 |
| Neurosurgical Procedures and Complications | 2021-2025 | 188 | US 85 | 91.26 |
| Botulinum Toxin and Related Neurological Disorders | 2021-2025 | 278 | US 61 | 90.83 |
| Olfactory and Sensory Function Studies | 2021-2025 | 247 | US 48 | 90.21 |
| Nicotinic Acetylcholine Receptors Study | 2021-2025 | 92 | US 35 | 88.56 |
| Cardiovascular Syncope and Autonomic Disorders | 2021-2025 | 170 | US 55 | 88.66 |
| Traumatic Brain Injury Research | 2021-2025 | 516 | US 275 | 88.95 |
| Pain Mechanisms and Treatments | 2021-2025 | 971 | US 264 | 80.33 |
| Neuropeptides and Animal Physiology | 2021-2025 | 763 | US 238 | 70.98 |
| Dental Anxiety and Anesthesia Techniques | 2021-2025 | 689 | US 55 | 68.81 |
